ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 013028 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$33M
Latest Revenue (FY2022)
+2.5%
Revenue CAGR (3yr)
11.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $31M | $34M | $33M | -4.3% | +2.5% |
| Operating Expenses | $27M | $30M | $29M | -2.9% | +2.8% |
| Operating Margin | 12.0% | 12.7% | 11.4% | -10.0% | -2.6% |
| Net Income | $4M | $4M | $4M | -13.9% | -0.2% |
| Licensed Beds | 70 | 80 | 75 | -6.2% | +3.5% |
| Total Patient Days | 23,702 | 24,941 | 23,960 | -3.9% | +0.5% |
| Medicare Day % | 53% | 51% | 53% | +4.3% | +0.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +5.0% ($31M → $33M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.5%
This Hospital
+7.6%
State Avg
Latest Margin
11.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | 11.1% |
| FY2024 (proj) | $34M | 10.8% |
| FY2025 (proj) | $35M | 10.5% |